PetVivo signs distribution agreement with Covetrus for veterinary syringes

PetVivo Holdings, Inc.

Appointed Covetrus as non-exclusive distributor for small and large animal syringes in US (ex-Puerto Rico) effective Jan 1, 2024.
Initial term of one year with automatic renewal; either party may non-renew with 30-day notice or terminate with cause.
Covetrus sets resale prices; PetVivo provides financial incentives based on product sales volume.
Agreement filed as exhibit to Q3 10-Q with certain confidential portions redacted.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

PetVivo Holdings, Inc. entered into Distribution Agreement with Covetrus North America, LLC valued at Non-exclusive distributor appointment with right to promote, market, distribute, and sell the Compan (effective 2024-01-01).

Action: entry
Agreement: supply
Counterparty: Covetrus North America, LLC
Value: Non-exclusive distributor appointment with right to promote, market, distribute, and sell the Compan
Effective: 2024-01-01

Exact text from the filing

On December 18, 2023, PetVivo Holdings, Inc. (the “Company”) entered into a Distribution Agreement (the “Agreement” or “Distribution Agreement”) with Covetrus North America, LLC (“Covetrus”), which has an effective date of January 1, 2024.

View on SEC.gov

Browse all material agreements →

PetVivo Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-045838

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.